These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7746712)

  • 1. Antibiotic therapy of neonates with bacterial sepsis.
    Edwards MS
    Pediatr Infect Dis J; 1995 Feb; 14(2):166-7. PubMed ID: 7746712
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic treatment for urinary tract infections in pediatric patients.
    Hellerstein S
    Minerva Pediatr; 2003 Oct; 55(5):395-406. PubMed ID: 14608263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone in treatment of serious infections. Septicemia.
    Foster MT
    Hosp Pract (Off Ed); 1991 Sep; 26 Suppl 5():43-7; discussion 62-3. PubMed ID: 1918222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern.
    Mokuolu AO; Jiya N; Adesiyun OO
    Afr J Med Med Sci; 2002 Jun; 31(2):127-30. PubMed ID: 12518907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient management of fever in selected infants.
    Perry RF; Garlisi AP
    N Engl J Med; 1994 Mar; 330(13):939; author reply 939-40. PubMed ID: 8114877
    [No Abstract]   [Full Text] [Related]  

  • 6. Should antibiotics be discontinued at 48 hours for negative late-onset sepsis evaluations in the neonatal intensive care unit?
    Kaiser JR; Cassat JE; Lewno MJ
    J Perinatol; 2002 Sep; 22(6):445-7. PubMed ID: 12168120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for a second dose of ceftriaxone in febrile infants age 4-8 weeks.
    Allen SE; Walsh-Kelly CM; Hennes HH
    WMJ; 2000 Apr; 99(2):60-2. PubMed ID: 10843028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone therapy of bacterial meningitis: cerebrospinal fluid concentrations and bactericidal activity after intramuscular injection in children treated with dexamethasone.
    Bradley JS; Farhat C; Stamboulian D; Branchini OG; Debbag R; Compogiannis LS
    Pediatr Infect Dis J; 1994 Aug; 13(8):724-8. PubMed ID: 7970973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative antibacterial prophylaxis in bone surgery: sufficiently high tissue levels with ceftriaxone (rocephin) 24 hours after a single dose of 2 g.
    Rudert W; Hennecke H; Adam D
    J Chemother; 1989 Jul; 1(4 Suppl):1046-7. PubMed ID: 16312765
    [No Abstract]   [Full Text] [Related]  

  • 10. Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbits.
    Bárcena-Varela S; Martínez-de-Tejada G; Martin L; Schuerholz T; Gil-Royo AG; Fukuoka S; Goldmann T; Droemann D; Correa W; Gutsmann T; Brandenburg K; Heinbockel L
    Exp Mol Med; 2017 Jun; 49(6):e345. PubMed ID: 28620220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory treatment with ceftriaxone in febrile neutropenic children.
    Kaplinsky C; Drucker M; Goshen J; Tamary H; Cohen IJ; Zaizov R
    Isr J Med Sci; 1994 Aug; 30(8):649-51. PubMed ID: 8045751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study.
    Roberts JA; Boots R; Rickard CM; Thomas P; Quinn J; Roberts DM; Richards B; Lipman J
    J Antimicrob Chemother; 2007 Feb; 59(2):285-91. PubMed ID: 17135183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [General and local antibiotic treatment with ceftriaxone of suppurative-septic diseases and complications].
    Mariutin PV; Uchvatkin VG; Rybin EP; Grakh SI; Sokirskiĭ EK
    Anesteziol Reanimatol; 1997; (3):14-8. PubMed ID: 9289978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effective use of once-daily ceftriaxone: overview of a symposium.
    Periti P
    Chemotherapy; 1991; 37 Suppl 3():26-7. PubMed ID: 1909230
    [No Abstract]   [Full Text] [Related]  

  • 15. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effective use of once-daily ceftriaxone in the treatment of moderate to severe infections: introduction to a symposium.
    Andriole VT
    Chemotherapy; 1991; 37 Suppl 3():1-2. PubMed ID: 1909227
    [No Abstract]   [Full Text] [Related]  

  • 17. Ambulatory treatment with intramuscular ceftriaxone.
    Schlaeffer F
    J Chemother; 1989 Jul; 1(4 Suppl):655-6. PubMed ID: 16312577
    [No Abstract]   [Full Text] [Related]  

  • 18. Six day antimicrobial therapy for early-onset group B streptococcal infection in near-term and term neonates.
    Pöschl JM; Hellstern G; Dertlioglou N; Ruef P; Meyburg J; Beedgen B; Linderkamp O
    Scand J Infect Dis; 2003; 35(5):302-5. PubMed ID: 12875514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient high-dose melphalan in multiple myeloma patients.
    Kassar M; Medoff E; Seropian S; Cooper DL
    Transfusion; 2007 Jan; 47(1):115-9. PubMed ID: 17207239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment: Clinical pharmaceutics and calcium ceftriaxone.
    Puzovic M; Hardy G
    Ann Pharmacother; 2008 Dec; 42(12):1914. PubMed ID: 19033487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.